Sirona Biochem (TSE:SBM) has released an update.
Sirona Biochem has announced strategic progress, including a successful Annual General Meeting and plans to launch its anti-aging product GlycoProteMim in Europe and North America in early 2025. The company faces financing challenges in the Canadian market but is exploring investment opportunities in Europe, North America, and Asia, as well as non-dilutive funding options. Sirona is also expanding its product line and has begun manufacturing custom cosmetic containers for an impending product launch.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.
